Energy metabolism as therapeutic target for aged wound repair by engineered extracellular vesicle

Yu Zhuang1, Shengjie Jiang1, Xiaoling Deng1

  • 1Department of Oral and Cranio-maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.

Science Advances
|April 12, 2024
PubMed

Insights

Metformin engineered extracellular vesicles (Met-EVs) rejuvenate aging skin by restoring cellular energy metabolism. This enhances wound repair in aged skin by improving mitochondrial function and mitophagy.

Area of Science:

  • Gerontology and Regenerative Medicine
  • Cellular Metabolism and Aging
  • Biotechnology and Nanomedicine

Background:

  • Aging skin exhibits impaired wound repair due to accumulated senescent cells (SnCs) and altered metabolic regulation.
  • Adequate adenosine triphosphate (ATP) production is crucial for cell activation and tissue repair in aged individuals.
  • Interventions targeting cellular ATP metabolism present a promising therapeutic avenue for age-related skin defects.

Purpose of the Study:

  • To investigate energy metabolic changes in aging skin.
  • To evaluate the efficacy of metformin engineered extracellular vesicles (Met-EVs) in ameliorating skin aging and enhancing repair.
  • To elucidate the underlying mechanisms of Met-EVs in restoring cellular function and ATP metabolism in aged skin.

Main Methods:

  • Analysis of energy metabolism in aging skin from human patients and mice.
  • Administration of Met-EVs to aged mice to assess skin repair efficacy.
  • Evaluation of cellular senescence, mitochondrial function, glycolysis, oxidative phosphorylation (OXPHOS), and mitophagy following Met-EV treatment.

Main Results:

  • Met-EV treatment significantly enhanced aged mouse skin repair and ameliorated cellular senescence.
  • Met-EVs restored cellular dysfunctions by remodeling ATP metabolism, characterized by reduced glycolysis and enhanced OXPHOS.
  • Met-EVs rescued senescence-induced mitochondrial dysfunctions and mitophagy suppressions, promoting adequate ATP production.

Conclusions:

  • Extracellular vesicles engineered with metformin (Met-EVs) can rejuvenate senescent cells and facilitate aged tissue repair.
  • The therapeutic effect of Met-EVs involves the remodeling of mitochondrial function via mitophagy for enhanced ATP production.
  • Disturbed energy metabolism in aging is a viable therapeutic target for improving age-related skin defects and promoting repair.